Ainos (NASDAQ:AIMD) Trading Down 8.4% – Should You Sell?

Ainos, Inc. (NASDAQ:AIMD) fell 8.4% on Wednesday . The company traded as low as $1.96 and last traded at $1.97. 19,583 shares were traded during trading, a decline of 38% from the average session volume of 31,702 shares. The stock had previously closed at $2.15.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Wall Street Zen upgraded shares of Ainos from a “sell” rating to a “hold” rating in a report on Friday, September 5th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ainos in a report on Monday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, Ainos presently has a consensus rating of “Sell”.

Ainos Price Performance

The stock has a market cap of $9.48 million, a PE ratio of -0.49 and a beta of 2.39. The business has a fifty day simple moving average of $2.85 and a two-hundred day simple moving average of $3.06. The company has a current ratio of 2.96, a quick ratio of 2.67 and a debt-to-equity ratio of 1.10.

Ainos (NASDAQ:AIMD) last released its quarterly earnings results on Thursday, November 13th. The company reported ($0.64) earnings per share for the quarter. The company had revenue of $0.00 million during the quarter.

Insider Buying and Selling at Ainos

In related news, major shareholder Carbon Nano Technology Taiwan sold 7,000 shares of the stock in a transaction dated Monday, October 6th. The shares were sold at an average price of $3.59, for a total value of $25,130.00. Following the completion of the transaction, the insider directly owned 1,037,206 shares in the company, valued at $3,723,569.54. This trade represents a 0.67% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 9.79% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Ainos

An institutional investor recently bought a new position in Ainos stock. Two Sigma Investments LP acquired a new stake in shares of Ainos, Inc. (NASDAQ:AIMD) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 23,008 shares of the company’s stock, valued at approximately $80,000. Two Sigma Investments LP owned about 0.48% of Ainos as of its most recent filing with the SEC.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.